Skip to content

Medical-device intelligence

CFP: Radioimmunoassay, Immunoreactive Insulin

FDA product code CFP: Radioimmunoassay, Immunoreactive Insulin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
CFP
FDA device name
Radioimmunoassay, Immunoreactive Insulin
Device class
1
Regulation number
862.1405
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

27 clearance records and 8 recall records in the covered releases, across 29 source company names and 1 product codes. Dated history runs from Sep 20, 1977 to Oct 7, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
CFP · Radioimmunoassay, Immunoreactive Insulin278

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

35 matching records
Device / recordCompany in FDA recordSourceSource date
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361Z-0921-2025 · CFPDRG International, Inc.RecallJan 15, 2025FDA classification date
Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410Z-0981-2024 · CFPBeckman Coulter, Inc.RecallFeb 5, 2024FDA classification date
ST-AIA PACK IRI; Part Number: 025260 Assay, DiabetesZ-2076-2018 · CFPTosoh Bioscience IncRecallJun 5, 2018FDA record creation date
ADVIA Centaur Systems Insulin ReadyPack; Test Code: IRI; Catalog Number: 02230141, for in vitro diagnostic use in the quantitative determination …Z-2086-2017 · CFPSiemens Healthcare Diagnostics, IncRecallApr 19, 2017FDA classification date
IMMULITE --- Insulin --- Catalog Number: LKIN1 (100 test), LKIN5 (500 tests) --- Test Code: INS, Color: Orange Product Usage: For in vitro…Z-1700-2012 · CFPSiemens Healthcare DiagnosticsRecallJun 2, 2012FDA classification date
IMMULITE 2000 --- Insulin --- Catalog Number: L2KIN2 (200 test), L2KIN6 (600 tests) --- Test Code: INS, Color: Orange --- Product Usage: For…Z-1701-2012 · CFPSiemens Healthcare DiagnosticsRecallJun 2, 2012FDA classification date
Access Ultrasensitive Insulin Assay Kit, Part Number 33410. The product is a paramagnetic particle, chemiluminescent immunoassay for the quantit…Z-1160-2008 · CFPBeckman Coulter IncRecallJun 25, 2008FDA classification date
Immulite 2500 insulin KitZ-0324-05 · CFPDiagnostic Products CorpRecallDec 17, 2004FDA classification date
ALPCO/MERCODIA INSULIN ELISAK963911 · CFPAmerican Laboratory Products Co., Ltd.510(k)Nov 1, 1996FDA decision date
ACCESS ULTRASENSITIVE INSULIN ASSAYK953084 · CFPBio-Rad Laboratories, Inc.510(k)Sep 25, 1995FDA decision date
IMX INSULINK920109 · CFPAbbott Laboratories510(k)May 7, 1992FDA decision date
DSL INSULIN RIA (DSL 1600)K914820 · CFPDiagnostic Systems Laboratories, Inc.510(k)Jan 9, 1992FDA decision date
AIA-PACK IRIK903628 · CFPTosoh Corp.510(k)Sep 7, 1990FDA decision date
ENZYMUN TEST(R) INSULINK901135 · CFPBoehringer Mannheim Corp.510(k)Apr 3, 1990FDA decision date
REP(TM) SPE PLUS-30 PROCEDURESK896572 · CFPHelena Laboratories510(k)Jan 11, 1990FDA decision date
RIA-GNOST INSULINK890837 · CFPCambridge Medical Technology510(k)Apr 26, 1989FDA decision date
PHARMACIA INSULIN RIAK851071 · CFPPharmacia, Inc.510(k)Apr 12, 1985FDA decision date
INSULIN RADIOIMMUNOASSAY KITK841573 · CFPSorin Biomedica, Fiat, USA, Inc.510(k)May 16, 1984FDA decision date
WAKO INSULIN TESTK823939 · CFPWako Chemicals USA, Inc.510(k)Jan 28, 1983FDA decision date
COVALENT COAT RIA KITK822509 · CFPImmuchem Corp.510(k)Sep 28, 1982FDA decision date
COAT-A-COUNT INSULIN KITK821861 · CFPDiagnostic Products Corp.510(k)Jul 8, 1982FDA decision date
ENZYMUNE-TEST INSULINK821374 · CFPIcl Scientific510(k)May 28, 1982FDA decision date
GAMMACOAT (125) INSULIN RADIOIMMUNOASSAYK812227 · CFPClinical Assays, Inc.510(k)Sep 24, 1981FDA decision date
IMMOPHASE INSULIN (125I) RADIOASSAYK811953 · CFPCorning Medical & Scientific510(k)Jul 23, 1981FDA decision date
VENTRE/SEPK811423 · CFPVentrex Laboratories, Inc.510(k)Jun 9, 1981FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗